Vor Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	160.46	81.94	31.36	57.71	119.8	48.54
Short-Term Investments	10	9.98	105.82	172.54	87.67	0.47
Cash & Short-Term Investments	170.46	91.92	137.18	230.25	207.47	49.01
Cash Growth	171.40%	-32.99%	-40.42%	10.98%	323.35%	657.90%
Other Current Assets	2.19	7	3.63	6.71	6.93	0.1
Total Current Assets	172.49	96.51	140.8	236.95	214.4	49.11
Net Property, Plant & Equipment	3.32	41.59	50.1	57.08	22.52	21.85
Other Long-Term Assets	0.27	2.38	7.23	5.34	5.67	4.96
Total Assets	176.24	142.89	198.13	299.37	242.59	75.91
Accounts Payable	0.89	1.51	0.82	1.77	1.55	2.36
Accrued Expenses	17.7	12.89	10.88	7.89	6.34	6.26
Current Portion of Leases	0.25	4.22	3.83	3.27	1.84	0.86
Other Current Liabilities	-	-	0.05	0.19	0.43	0.72
Total Current Liabilities	18.84	18.61	15.57	13.12	10.15	10.21
Long-Term Leases	2.81	27.62	31.83	35.64	16.17	17.43
Total Long-Term Liabilities	2.81	27.62	31.83	35.64	16.17	17.43
Total Liabilities	2,402	46.23	47.4	48.76	26.33	27.64
Common Stock	0.02	0.01	0.01	0.01	0	0
Additional Paid-in Capital	650.32	553.62	490.87	473.59	346.38	2.16
Accumulated Other Comprehensive Income	0.02	0.02	-0.08	-0.77	-	-
Retained Earnings	-2,876	-456.99	-340.08	-222.22	-130.12	-61.22
Total Common Shareholders' Equity	-2,225	96.66	150.72	250.61	216.26	-59.07
Minority Interest	-	-	-	-	-	107.34
Shareholders' Equity	-2,225	96.66	150.72	250.61	216.26	48.27
Total Liabilities & Equity	176.24	142.89	198.13	299.37	242.59	75.91
Total Debt	3.06	31.83	35.66	38.91	18.01	18.29
Net Cash (Debt)	167.4	60.09	101.52	191.33	189.46	30.71
Net Cash Growth	178.60%	-40.81%	-46.94%	0.99%	516.86%	374.99%
Net Cash Per Share	29.52	17.49	30.22	96.75	113.33	2874.97
Book Value	-2,225	96.66	150.72	250.61	216.26	-59.07
Book Value Per Share	-392.38	28.14	44.86	126.72	129.37	-5528.93
Tangible Book Value	-2,225	96.66	150.72	250.61	216.26	-59.07
Tangible Book Value Per Share	-392.38	28.14	44.86	126.72	129.37	-5528.93

Updated Nov 13, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q